Murray, JL & Lopez, AD (1996) The Global Burden of Disease: A Comprehensive Assessment of Global Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Geneva: World Health Organization.
Adlercreutz, H, Markkanen, H & Watanabe, S (1998) Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 342, 1209–1210.
Scheiber, MD, Liu, JH, Subbiah, MTR, Rebar, RW & Setchell, KDR (2001) Dietary inclusion of whole soy foods results in significant reductions in clinical risk factors for osteoporosis and cardiovascular disease in normal postmenopausal women. Menopause 8, 384–392.
Fielding, CJ & Fielding, PE (1995) Molecular physiology of reverse cholesterol transport. J Lipid Res 36, 211–228.
Gustafsson, JA (1999) Estrogen receptor β – a new dimension in estrogen mechanism of action. J Endocrinol 163, 379–383.
Shutt, DA & Cox, RI (1972) Steroid and phyto-estrogen binding to sheep uterine receptors in vitro. J Endocrinol 52, 291–310.
Kuiper, GGJM, Lemmen, JG, Carlsson, B, Corton, JC, Safe, SH, van der Saag, PT, van der Burg, B & Gustafsson, JA (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology. 139, 4252–4263.
Adlercreutz, H (2003) Phytoestrogens and breast cancer. J Steroid Biochem Mol Biol 83, 113.
Jefferson, WN, Padilla-Banks, E, Clark, G & Newbold, RR (2002) Assessing estrogenic activity of phytochemicals using transcriptional activation and immature mouse uterotrophic responses. J Chromatogr B Analyt Technol. Biomed Life Sci 777, 179.
Javitt, NB (1990) HepG2 cells as a resource for metabolic studies: lipoprotein, cholesterol and bile acids. FASEB J 4, 161–168.
Rash, JM, Rothblat, GH & Sparks, CE (1981) Lipoprotein apolipoprotein synthesis by human hepatoma cells in culture. Biochim Biophys Acta 666, 294–298.
Zannis, VI, Breslow, JL, SanGiacomo, TR, Aden, DP & Knowles, BB (1981) Characterization of the major apolipoproteins secreted by two human hepatoma cell lines. Biochemistry 20, 7089–7096.
Harnish, DC, Evans, MJ, Scicchitano, MS, Bhat, RA & Karathanasis, SK (1998) Estrogen regulation of the apolipoprotein AI gene promoter through transcription cofactor sharing. J Biol Chem 273, 9270–9278.
Livak, KJ & Schmittgen, TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402–408.
Mosmann, T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65, 55–63.
Lamon-Fava, S & Micherone, D (2004) Regulation of apoA-I gene expression mechanism of action of estrogen and genistein. J Lipid Res 45, 106–112.
Beers, A, Haas, MJ, Wong, NCW & Mooradian, AD (2006) Inhibition of apolipoprotein AI gene expression by tumor necrosis factor α: roles for MEK/ERK and JNK signaling. Biochemistry 45, 2408–2413.
Lamon-Fava, S, Ordovas, M & Schaefer, EJ (1999) Estrogen increases apolipoprotein (apo) A-1 secretion in HepG2 cells by modulating transcription of the apoA-1 gene promoter. Arterioscler Thromb Vasc Biol 19, 2960–2965.
Lamon-Fava, S (2000) Genistein activates apolipoprotein A-1 gene expression in the human hepatoma cell line HepG2. J Nutr 130, 2489–2492.
Sastry, KN, Seedorf, U & Karthanasis, SK (1988) Different cis-acting DNA elements control expression of the human apolipoprotein AI gene in different cell types. Mol Cell Biol 8, 605–614.
Harnish, DC, Malik, S, Kilbourne, E, Costa, R & Karathanasis, SK (1996) Control of apolipoprotein A-I gene expression through synergistic interaction between hepatocyte nuclear factors 3 and 4. J Biol Chem 271, 13621–13628.
Harnish, DC, Malik, S & Karathanasis, SK (1994) Activation of apolipoprotein A-I gene expression by the liver-enriched factor HNF-3. J Biol Chem 269, 28220–28226.
Kilbourne, E, Widom, R, Harnish, DC, Malik, S & Karathanasis, SK (1995) Involvement of early growth response factor Egr1 in apolipoprotein AI gene transcription. J Biol Chem 270, 7004–7010.
Ivanov, GS, Kater, JM, Jha, SH, Stutius, EA, Sabharwal, R, Tricarico, MD, Ginsburg, GS & Ozer, JS (2003) Sp and GATA factors are critical for apolipoprotein AI downstream enhancer activity in human HepG2 cells. Gene 323, 31–42.
Zhang, X, Jiao, JJ, Bhavnani, BR & Tam, SP (2001) Regulation of human apolipoprotein A-1 gene expression by equine estrogens. J Lipid Res 42, 1789–1800.